Brief

The MHRA allows Manufacturers Specials (MS) licence holders to pack down large packs of licenced medicinal products into smaller quantities for distribution to community pharmacies during the COVID-19 outbreak. This activity must be notified to the MHRA, and labels should meet routine requirements with the MS number included. The packaging details should also be provided in the notification. This guidance only applies during the pandemic, enabling supply continuity at the local level.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies